Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Ear (Q42641710)
Jump to navigation
Jump to search
scientific article published on December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Ear |
scientific article published on December 2009 |
Statements
1 reference
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Ear (English)
1 reference
1 reference
Christopher B Granger
1 reference
Matthew T Roe
1 reference
Robert A Harrington
1 reference
Pawel Buszman
1 reference
Cindy L Grines
1 reference
Uwe Zeymer
1 reference
Rakhi Kilaru
1 reference
Jeffrey S Berger
1 reference
C Michael Gibson
1 reference
Cynthia L Green
1 reference
Laura Melton
1 reference
James D Blankenship
1 reference
D Christopher Metzger
1 reference
Daniel D Gretler
1 reference
Kurt Huber
1 reference
1 December 2009
1 reference
1 reference
Identifiers
1 reference